Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation

European Journal of Clinical Pharmacology

Volumn 65, Issue 5, 2009, Pages 523-531

  Gendron, Marie Pierre ^a,b   Martin, Brigitte ^b   Oraichi, Driss ^b   Bérard, Anick ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cross sectional study; IMAGe; Lactation; Medications; Predictors; Pregnancy

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIINFLAMMATORY AGENT; BENZODIAZEPINE DERIVATIVE;

ARTICLE; HEALTH CARE PERSONNEL; LACTATION; MEDICAL INFORMATION; MEDICAL SERVICE; PREGNANCY; PRIORITY JOURNAL;

CANADA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; INFORMATION SERVICES; LACTATION; PHARMACEUTICAL PREPARATIONS; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; TERATOGENS;

EID: 65349145475     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0611-6     Document Type: Article

References (40)

1. SE Andrade JH Gurwitz RL Davis KA Chan JA Finkelstein K Fortman 2004 Prescription drug use in pregnancy Am J Obstet Gynecol 191 2 398 407
2. VC De HE De Walle S Cordier J Goujard R Knill-Jones S Ayme 1999 Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational Exposures and Congenital Anomalies J Clin Epidemiol 52 10 977 82
3. H Malm J Martikainen T Klaukka PJ Neuvonen 2003 Prescription drugs during pregnancy and lactation-a Finnish register-based study Eur J Clin Pharmacol 59 2 127 33
4. C Olesen FH Steffensen GL Nielsen LT de Jong-van den Berg J Olsen HT Sorensen 1999 Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group Eur J Clin Pharmacol 55 2 139 44
5. V Egen-Lappe J Hasford 2004 Drug prescription in pregnancy: analysis of a large statutory sickness fund population Eur J Clin Pharmacol 60 9 659 66
6. J Headley K Northstone H Simmons J Golding 2004 Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children Eur J Clin Pharmacol 60 5 355 361
7. I Lacroix C Damase-Michel M Lapeyre-Mestre JL Montastruc 2000 Prescription of drugs during pregnancy in France Lancet 356 9243 1735 1736
8. JS Refuerzo SC Blackwell RJ Sokol L Lajeunesse K Firchau M Kruger 2005 Use of over-the-counter medications and herbal remedies in pregnancy Am J Perinatol 22 6 321 324
9. MN Beyens C Guy M Ratrema M Ollagnier 2003 Prescription of drugs to pregnant women in France: the HIMAGE study Therapie 58 6 505 511
10. E Schirm MP Schwagermann H Tobi LT De Jong-Van Den Berg 2004 Drug use during breastfeeding. A survey from the Netherlands Eur J Clin Nutr 58 2 386 390
11. B Ofori D Oraichi L Blais E Rey A Berard 2006 Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study Birth Defects Res B Dev Reprod Toxicol 77 4 268 279
12. D Garriguet 2006 Medication use among pregnant women Health Rep 17 2 9 18
13. I Matheson K Kristensen PK Lunde 1990 Drug utilization in breast-feeding women. A survey in Oslo Eur J Clin Pharmacol 38 5 453 459
14. EE Stultz JL Stokes ML Shaffer IM Paul CM Berlin 2007 Extent of medication use in breastfeeding women Breastfeed Med 2 3 145 151
15. E Sanz T Gomez-Lopez MJ Martinez-Quintas 2001 Perception of teratogenic risk of common medicines Eur J Obstet Gynecol Reprod Biol 95 1 127 131
16. Medications pal. (2005-2006) Pharmaceutical chair Louis-Boivin family. Annual report
17. Health Canada (2008) Health Canada Drug Product Database (DPD). Available at: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index-eng.php
18. World Health Organization (WHO) (2008). Anatomical Therapeutic Chemical (ATC) classification. Available at: http://www.whocc.no/atcddd/atcsystem.html
19. MSSO (2008) MedDRA terminology. Available at: http://www.meddramsso.com
20. Health Canada (2004) New safety information regarding paroxetine: findings suggest increased risk over other antidepressants, of congenital malformations following first trimester exposure to paroxetine. Available at: http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/-2004/2004-44-eng.php
21. Health Canada (2006) Newer antidepressants linked to serious lung disorder in newborns. http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/- 2006/2006-11-eng.php
22. Health Canada (2004) CELEBREX (celecoxib) capsules important safety information. Available at: http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories- avis/prof/-2004/celebrex-2-hpc-cps-eng.php
23. Health Canada (2004). Merck Sharp & Dohme (MSD) announces voluntary worldwide withdrawal of VIOXX (rofecoxib). Available at: http://www.hc-sc.gc.ca/ dhp-mps/medeff/advisories-avis/prof/-2004/vioxx-2-ltp-lp-eng.php
24. US Food and Drug Administration (2005). FDA announces important changes and additional warnings for COX-2 selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs). Available at: http://www.fda.gov/cder/drug/ advisory/COX2.htm
25. DK Li L Liu R Odouli 2003 Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study Br Med J 327 7411 368
26. A Einarson G Portnoi G Koren 2002 Update on motherisk updates. Seven years of questions and answers Can Fam Physician 48 1301 1304
27. SM De E Cesari MS Ligato E Nobili G Straface A Cavaliere 2008 Prenatal drug exposure and teratological risk: One-year experience of an Italian Teratology Information Service Med Sci Monit 14 2 H1 H8
28. MP Austin PB Mitchell 1998 Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment Aust N Z J Psychiatry 32 6 778 84
29. E Ramos D Oraichi E Rey L Blais A Berard 2007 Prevalence and predictors of antidepressant use in a cohort of pregnant women Br J Obstet Gynaecol 114 9 1055 1064
30. SD Ho-Yen GT Bondevik M Eberhard-Gran B Bjorvatn 2007 Factors associated with depressive symptoms among postnatal women in Nepal Acta Obstet Gynecol Scand 86 3 291 297
31. B Zuckerman H Amaro H Bauchner H Cabral 1989 Depressive symptoms during pregnancy: relationship to poor health behaviors Am J Obstet Gynecol 160 5 Pt 1 1107 1111
32. ML Zilberman H Tavares SB Blume N el-Guebaly 2003 Substance use disorders: sex differences and psychiatric comorbidities Can J Psychiatry 48 1 5 13
33. U Amann V Egen-Lappe C Strunz-Lehner J Hasford 2006 Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population Pharmacoepidemiol Drug Saf 15 5 327 337
34. Quebec government (2008). The fight against smoking. Available at: http://msss.gouv.qc.ca/sujets/santepub/tabac/index.php?aid=98
35. C Bullen 2008 Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease Expert Rev Cardiovasc Ther 6 6 883 895
36. AL Nightingale RA Lawrenson EL Simpson TJ Williams KD tmp MacRae RD Farmer 2000 The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives Eur J Contracept Reprod Health Care 5 4 265 274
37. S Roy 1999 Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives Am J Obstet Gynecol 180 6 Pt 2 S364 S368
38. M Karsak E Gaffal R Date L Wang-Eckhardt J Rehnelt S Petrosino 2007 Attenuation of allergic contact dermatitis through the endocannabinoid system Science 316 5830 1494 1497
39. K Demyttenaere A Bonnewyn R Bruffaerts GG De I Gasquet V Kovess 2008 Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD) J Affect Disord 110 1-2 84 93
40. Statistics Canada, Canada's national statistical agency (2007). Births 2005. Available at: http://www.statcan.ca/bsolc/english/bsolc?catno=84F0210X 84F0210XWE